(PDF) Cost-Utility Analysis of Lurasidone Versus

Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults With Schizophrenia

PharmacoEconomics - United Kingdom

doi 10.1007/s40273-016-0405-0

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

April 11, 2016

Authors

Krithika Rajagopalan

Daniel Squirrell

Publisher

Springer Science and Business Media LLC

Related search

Cost-Effectiveness Analysis of Lurasidone and Olanzapine in the Treatment of Schizophrenia

Value in Health

Occupational Health

English

Efficacy and Metabolic Effects of Lurasidone Versus Brexpiprazole in Schizophrenia: A Network Meta-Analysis

Journal of Comparative Effectiveness Research

English

A Cost Utility Analysis of CYP2D6 Pharmacogenetic Guided Dosing Versus Standard Dosing of Risperidone for Treatment of Schizophrenia

Value in Health

Occupational Health

English

Pmd36 - Budget Impact Analysis of the Use of Lurasidone in Patients With Schizophrenia in Italy

Value in Health

Occupational Health

English

A Cost-Utility Analysis of Amisulpride and Paliperidone in the Treatment of Schizophrenia

Multidisciplinary

English

Cost/Effectiveness of Aripiprazole vs. Olanzapine in the Long-Term Treatment of Schizophrenia

Srpski Arhiv Za Celokupno Lekarstvo

English

Cost-Utility Analysis of Secukinumab Use Versus TNF-Α Inhibitors, in Patients With Ankylosing Spondilytis

Value in Health

Occupational Health

English

Pmh25 - Early Administration of Aripiprazole Long-Acting Injectable in Acute Inpatients With Schizophrenia Reduces the Cost of Hospitalization

Value in Health

Occupational Health

English

PDB60 a Cost-Utility Analysis of Pregabalin Versus Duloxetine in Painful Diabetic Neuropathy

Value in Health

Occupational Health

English